54741_Image_jpeg.jpg
Daxor Corporation Appoints Kathryn A. Kornafel Vice President of Marketing and Commercial Development
12 juin 2018 08h30 HE | Daxor Corporation
NEW YORK , June 12, 2018 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an innovative medical instrumentation and biotechnology company focused on blood volume measurement today announces...
54741_Image_jpeg.jpg
Daxor Corporation Initiates Study with Virginia Commonwealth University to Measure Improvement of Survival Rates Following Burn Surgery As A Result of Optimized Blood Volume Assessment
04 juin 2018 08h30 HE | Daxor Corporation
NEW YORK, June 04, 2018 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an innovative medical instrumentation and biotechnology company focused on blood volume measurement today announces the...
54741_Image_jpeg.jpg
Daxor Corporation to Present at the LD Micro 8th Annual Invitational on June 4, 2018
30 mai 2018 08h30 HE | Daxor Corporation
NEW YORK, May 30, 2018 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an innovative medical instrumentation and biotechnology company focused on blood volume measurement, announced that...
54741_Image_jpeg.jpg
Daxor Corporation Retains CORE IR as Investor Relations Firm of Record
29 mai 2018 08h30 HE | Daxor Corporation
NEW YORK, May 29, 2018 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an innovative medical instrumentation and biotechnology company focused on blood volume measurement today announces it...
54741_Image_jpeg.jpg
A New Study Published in The Annals of Thoracic Surgery: Daxor’s BVA-100 Device Reveals Unexpected Blood Loss of 38% in Cardiac Surgical Patients Not Detected by Common Test in Use
19 avr. 2018 09h00 HE | Daxor Corporation
New York, NY, April 19, 2018 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with medical instrumentation and biotechnology operations, announces the publication of new...
54741_Image_jpeg.jpg
Daxor to Present at The MicroCap Conference on April 9th and 10th in New York City at the Essex House
05 avr. 2018 09h00 HE | Daxor Corporation
New York, NY, April 05, 2018 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with medical instrumentation and biotechnology operations, announces it will present at...
54741_Image_jpeg.jpg
Daxor to Exhibit at the American Association of Heart Failure Nurses 2018 Advanced Heart Failure Symposium
22 mars 2018 09h00 HE | Daxor Corporation
New York, NY, March 22, 2018 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with medical instrumentation and biotechnology operations, announces it will exhibit for the...
54741_Image_jpeg.jpg
New Data Showing Patient Care Individualized by Daxor’s Precision Blood Volume Analysis Reduces Heart Failure Readmissions by 56% and Mortality by over 80% Presented at the American College of Cardiology 2018 Annual Scientific Session
14 mars 2018 08h00 HE | Daxor Corporation
(NYSE MKT LLC: DXR) New York, NY, March 14, 2018 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with medical instrumentation and biotechnology operations,...
54741_Image_jpeg.jpg
Daxor Corporation Announces Positive New Critical Care Research Highlighting Benefit from BVA Use; Daxor Corporation to Exhibit at the American College of Cardiology 2018 Annual Meeting (NYSE MKT LLC: DXR)
09 mars 2018 11h55 HE | Daxor Corporation
New York, NY, March 09, 2018 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with medical instrumentation and biotechnology operations, exhibited at the 2018 Society for...
54741_Image_jpeg.jpg
Daxor Corporation Announces Rise in Kit Sales, New Device Sale, and Filing of Form N-CSR for 2017 (NYSE MKT LLC: DXR)
08 mars 2018 12h56 HE | Daxor Corporation
New York, NY, March 08, 2018 (GLOBE NEWSWIRE) -- Daxor Corporation, (NYSE MKT: DXR) an investment company with medical instrumentation and biotechnology operations, filed a Form N-CSR disclosing its...